《Epilepsia》雜志的最新年發文量為309篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章，以保持其在臨床神經病學領域的學術影響力。
該刊聚焦于醫學-臨床神經病學領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 較快,2-4周 。
Epilepsia 雜志發文統計
文章名稱引用次數
- The epidemiology of drug-resistant epilepsy: A systematic review and meta-analysis44
- Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions43
- Commonalities in epileptogenic processes from different acute brain insults: Do they translate?40
- Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial35
- New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives34
- Diagnostic outcomes for genetic testing of 70 genes in 8565 patients with epilepsy and neurodevelopmental disorders34
- Deep brain stimulation for drug-resistant epilepsy31
- Effects of surgical targeting in laser interstitial thermal therapy for mesial temporal lobe epilepsy: A multicenter study of 234 patients29
- Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program results25
- Laser ablation for mesial temporal lobe epilepsy: Surgical and cognitive outcomes with and without mesial temporal sclerosis24
國家/地區發文量
- USA588
- England306
- Italy236
- GERMANY (FED REP GER)229
- Australia145
- Canada138
- France134
- CHINA MAINLAND117
- Japan115
- Netherlands108
